Compare Merck & Company (6MK) vs. Competitors

0 Followers

Comparison Results

6MK

Merck & Company

CHF96.58

CHF297.99B

115.56

0.00%

15 Buy

6 Hold

0 Sell

Moderate Buy

Bristol-Myers Squibb

$64.72

$120.77B

13.02

32.32%

8 Buy

12 Hold

1 Sell

Moderate Buy

Johnson & Johnson

$273.14

$630.04B

30.22

36.82%

14 Buy

4 Hold

0 Sell

Strong Buy

Novartis

$159.98

$262.82B

21.76

9.68%

3 Buy

3 Hold

1 Sell

Moderate Buy

Pfizer

$28.57

$161.19B

37.37

12.04%

8 Buy

14 Hold

1 Sell

Moderate Buy

AbbVie

$265.79

$488.55B

77.89

19.84%

20 Buy

4 Hold

0 Sell

Strong Buy

xxxxxxxxxxxxx

6MK vs ABBV

xxxxxxxxxxxxx

Performance Comparison

CH:6MK

Merck & Company

96.58

0.00

0.00%

BMY

Bristol-Myers Squibb

59.12

17.43

41.83%

JNJ

Johnson & Johnson

261.44

74.75

40.04%

NVS

Novartis

143.75

17.11

13.51%

PFE

Pfizer

28.28

5.17

22.38%

ABBV

AbbVie

276.47

53.10

23.77%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >